Seaport Therapeutics, Inc SPTX
—
21.52
0.40
1.89%
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow SPTX
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
18.00 | 13.24 | 17.46 | — |
+2 more quarters Free account |
Net Debt/EBITDA |
4.15 | 6.66 | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | — | — | |
Operating CF/Net income |
0.42 | 0.79 | 0.00 | 1.02 | |
Capex/Depreciation |
0.00 | 0.00 | 0.18 | 0.32 | |
Interest Coverage |
0.00 | 0.00 | — | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | — | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | 0.00% | |
Free Cash Flow per Share |
(0.74) | (8.21) | 0.00 | (6.62) | |
Cash per Share |
7.76 | 74.33 | 0.00 | 0.00 | |
Shareholders Equity per Share |
11.99 | 85.36 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.99 | 85.36 | 0.00 | 0.00 | |
Free Cash Flow |
(26.14) | (20.17) | (78.30) | (15.59) | |
Working Capital |
266.50 | 174.12 | 210.45 | — | |
Capital Expenditures |
— | — | (0.36) | (0.27) | |
Net Current Asset Value |
263.10 | 170.38 | 207.00 | 0.00 | |
| Other line items | |||||
Quick Ratio |
17.44 | 12.84 | 16.90 | — | |
Revenue per Share |
0.00 | 0.00 | — | 0.00 | |
Operating CF per Share |
(0.74) | (8.21) | 0.00 | (6.50) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.11) | |
Average Assets |
220.84 | 271.73 | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | — | 0.00% |
Columns are period end dates